Insulin Resistance and Pathogenesis of Postmenopausal Osteoporosis
Author:
- 1 January 2023
- journal article
- review article
- Published by ACTA Endocrinologica Foundation in Acta Endocrinologica (Bucharest)
- Vol. 19 (3) , 349-363
Abstract
Osteoporosis (OP) is a disease predisposing postmenopausal women to fractures, and often accompanied by insulin resistance (IR) and metabolic syndrome (MetS). Previous studies provided contradictory results concerning prevalence of MetS in postmenopausal OP. To better understand the pathogenesis of IR, we reviewed cellular and molecular aspects and systematically reviewed studies providing homeostasis model assessment (HOMA) index. Bone is an active endocrine organ maintaining its integrity by orchestrated balance between bone formation and resorption. Both osteoblasts and osteoclasts contain receptors for insulin and insulin-like growth factor-1 (IGF-1) operating in skeletal development and in the adult life. Defects in this system generate systemic IR and bone-specific IR, which in turn regulates glucose homeostasis and energy metabolism through osteocalcin. Examination of genetic syndromes of extreme IR revealed intriguing features namely high bone mineral density (BMD) or accelerated growth. Studies of moderate forms of IR in postmenopausal women reveal positive correlations between HOMA index and BMD while correlations with osteocalcin were rather negative. The relation with obesity remains complex involving regulatory factors such as leptin and adiponectin to which the contribution of potential genetic factors and in particular, the correlation with the degree of obesity or body composition should be added.Keywords
This publication has 99 references indexed in Scilit:
- Effect of natural menopause on serum levels of IGF-I and IGF-binding proteins: relationship with bone mineral density and lipid metabolism in perimenopausal womenEuropean Journal of Endocrinology, 1997
- Osf2/Cbfa1: A Transcriptional Activator of Osteoblast DifferentiationCell, 1997
- Identification of Two Novel Insulin Receptor Mutations, Asp59Gly and Leu62Pro, in Type A Syndrome of Extreme Insulin ResistanceBiochemical and Biophysical Research Communications, 1997
- Insulin-Like Growth FactorsNew England Journal of Medicine, 1997
- Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transductionNature, 1995
- Involvement of phosphoinositide 3‐kinase in insulin‐ or IGF‐1‐induced membrane ruffling.The EMBO Journal, 1994
- Acute Response to Recombinant Insulin-like Growth Factor I in a Patient with Mendenhall's SyndromeNew England Journal of Medicine, 1990
- The characterization, regulation, and function of insulin receptors on osteoblast-like clonal osteosarcoma cell lineJournal of Bone and Mineral Research, 1989
- The insulin receptor and the molecular mechanism of insulin action.Journal of Clinical Investigation, 1988
- Defect in insulin receptor phosphorylation in erythrocytes and fibroblasts associated with severe insulin resistance.Journal of Biological Chemistry, 1984